Real-World Persistence in Adults with HIV and Mental Health or Substance Use Disorders After Restarting Antiretroviral Therapy in the United States
For PWH-MHD/SUD who restarted ART after a treatment interruption, B/F/TAF was associated with longer persistence and the lowest risk of switch compared with other guideline-recommended therapies.
Authors
- Daniel Joseph (ORCID: https://orcid.org/0000-0003-2283-421X)
- Peter McMahon (ORCID: https://orcid.org/0000-0002-4947-2952)
- Mary J. Christoph (ORCID: https://orcid.org/0000-0001-8769-9931)
- Amanda M. Kong (ORCID: https://orcid.org/0000-0002-6210-4185)
- Travis Lim (ORCID: https://orcid.org/0000-0003-1662-7329)
- Neia Prata Menezes (ORCID: https://orcid.org/0000-0001-9597-7348)
- Daniela Yucumá (ORCID: https://orcid.org/0000-0002-3815-7244)
- Jacqueline Lucia
- Gülce Askin (ORCID: https://orcid.org/0000-0001-5126-9809)
- Uche Mordi
Institutions
- Aetion (United States) (US)
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1007/s12325-025-03379-1
- Citations
- 3
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Gilead Sciences